PUBLISHER: TechNavio | PRODUCT CODE: 2126205
PUBLISHER: TechNavio | PRODUCT CODE: 2126205
Global Multiomics Market 2026-2030
The global multiomics market is forecasted to grow by USD 3286.1 mn during 2025-2030, accelerating at a CAGR of 15.4% during the forecast period. The report on the global multiomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for personalized medicine and precision oncology, technological advancements in next-generation sequencing and high-throughput mass spectrometry, increasing strategic collaborations and pharmaceutical research investments.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 13.3% |
| CAGR | 15.4% |
| Incremental Value | $3286.1 mn |
Technavio's global multiomics market is segmented as below:
By Component
- Products
- Services
By Type
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Epigenomics
By Technology
- Bulk multiomics
- Single cell multiomics
- Spatial multiomics
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- The Netherlands
- Italy
- Spain
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of ai and ml for complex multiomics data harmonization as one of the prime reasons driving the global multiomics market growth during the next few years. Also, emergence of spatial multiomics and single-cell multi-layered profiling and expansion of multiomics applications in agricultural biotechnology will lead to sizable demand in the market.
The report on the global multiomics market covers the following areas:
- Global multiomics market sizing
- Global multiomics market forecast
- Global multiomics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global multiomics market vendors that include 10X Genomics Inc., Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Bio Techne Corp., Bruker Corp., Element Biosciences Inc., F. Hoffmann La Roche Ltd., Illumina Inc., Leica Biosystems Nussloch GmbH, Miltenyi Biotec BV and Co. KG, Mission Bio Inc., Oxford Nanopore Technologies, QIAGEN N.V., Revvity Inc., Shimadzu Corp., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp.. Also, the global multiomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Component
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Multiomics Market 2020 - 2024
- Historic Market Size - Data Table on Global Multiomics Market 2020 - 2024 ($ million)
- 5.2 Component segment analysis 2020 - 2024
- Historic Market Size - Component Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Multiomics Market
- 6.2 Impact of Geopolitical Conflicts on Global Multiomics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Component
- 8.1 Market segments
- 8.2 Comparison by Component
- 8.3 Products - Market size and forecast 2025-2030
- 8.4 Services - Market size and forecast 2025-2030
- 8.5 Market opportunity by Component
- Market opportunity by Component ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Genomics - Market size and forecast 2025-2030
- 9.4 Transcriptomics - Market size and forecast 2025-2030
- 9.5 Proteomics - Market size and forecast 2025-2030
- 9.6 Metabolomics - Market size and forecast 2025-2030
- 9.7 Epigenomics - Market size and forecast 2025-2030
- 9.8 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 Bulk multiomics - Market size and forecast 2025-2030
- 10.4 Single cell multiomics - Market size and forecast 2025-2030
- 10.5 Spatial multiomics - Market size and forecast 2025-2030
- 10.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 The Netherlands - Market size and forecast 2025-2030
- 12.4.5 Italy - Market size and forecast 2025-2030
- 12.4.6 Spain - Market size and forecast 2025-2030
- 12.4.7 Russia - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Singapore - Market size and forecast 2025-2030
- 12.5.7 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Australia - Market size and forecast 2025-2030
- 12.6.2 Brazil - Market size and forecast 2025-2030
- 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.4 UAE - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising demand for personalized medicine and precision oncology
- Technological advancements in next-generation sequencing and high-throughput mass spectrometry
- Increasing strategic collaborations and pharmaceutical research investments
- 13.2 Market challenges
- High capital expenditure and instrumentation costs
- Data integration, computational complexity, and bioinformatics bottlenecks
- Regulatory ambiguities and standardized clinical validation deficits
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of AI and ML for complex multiomics data harmonization
- Emergence of spatial multiomics and single-cell multi-layered profiling
- Expansion of multiomics applications in agricultural biotechnology
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 10X Genomics Inc.
- 10X Genomics Inc. - Overview
- 10X Genomics Inc. - Product / Service
- 10X Genomics Inc. - Key offerings
- SWOT
- 15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.6 Azenta Inc.
- Azenta Inc. - Overview
- Azenta Inc. - Business segments
- Azenta Inc. - Key offerings
- Azenta Inc. - Segment focus
- SWOT
- 15.7 BGI Genomics Co. Ltd.
- BGI Genomics Co. Ltd. - Overview
- BGI Genomics Co. Ltd. - Product / Service
- BGI Genomics Co. Ltd. - Key offerings
- SWOT
- 15.8 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.9 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
- 15.10 Bruker Corp.
- Bruker Corp. - Overview
- Bruker Corp. - Business segments
- Bruker Corp. - Key offerings
- Bruker Corp. - Segment focus
- SWOT
- 15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.12 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.13 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.14 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.15 Shimadzu Corp.
- Shimadzu Corp. - Overview
- Shimadzu Corp. - Business segments
- Shimadzu Corp. - Key offerings
- Shimadzu Corp. - Segment focus
- SWOT
- 15.16 Takara Bio Inc.
- Takara Bio Inc. - Overview
- Takara Bio Inc. - Product / Service
- Takara Bio Inc. - Key offerings
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 Waters Corp.
- Waters Corp. - Overview
- Waters Corp. - Business segments
- Waters Corp. - Key offerings
- Waters Corp. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
